InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Biotech case law: Pitfalls and opportunities in biotech and pharma patenting


Hendrik Wichmann and Fritz Lahrtz of Isenbruck Bösl Hörschler Wichmann Huhn outline how differences between German and EPO patent law are causing problems for patent applicants

Several recent EPO Appeal Board decisions highlight the principle of the European patent system that exclusive rights shall only be granted in exchange for a full disclosure of the invention. This strict practice is particularly important for pharma and biotech...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

nullnullnull

null

July /August 2019

AI and IP: the view from above

Managing IP speaks to the directors of WIPO and the EUIPO to gauge their views on AI, asking how the technology can help the offices be more efficient and whether job losses are inevitable



Most read articles

Supplements